The drug, nirsevimab, was effective against respiratory syncytial virus infections when used in the Yukon-Kuskokwim Delta, a region known for high rates of that disease among infants, said the report.

Yesterday, officials in British Columbia (BC) reported a fourth case of chronic wasting disease (CWD) in the Kootenay region ...

CHICAGO – Now that colder temperatures have arrived, the Illinois Department of Public Health (IDPH) is reminding Illinoisans ...

SummaryState warns of rising COVID threat, surge in Whooping Cough cases The Illinois Department of Public Health is ...

There has been a "dramatic" decrease in cases of RSV among babies due to a new vaccine but flu is rising and expected to peak after Christmas, the interim chief medical officer said. Usually one in ...

Respiratory syncytial virus (RSV) is an infectious respiratory disease that can look and sound a lot like a cold, with ...

RSV is the most common cause of hospitalization in infants under 1 year old. The infection can spread to the lungs and cause ...

IDWeek 2024 was held at the Los Angeles Convention Center in Downtown Los Angeles, CA, USA, from 16–19 October. Phoebe Hall ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

A presentation at the National Community Pharmacists Association Annual Meeting and Exposition focused on the latest on vaccines for flu and respiratory syncytial virus (RSV).

Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, ...